ERYTHROMYCIN tablet film coated

国: アメリカ合衆国

言語: 英語

ソース: NLM (National Library of Medicine)

有効成分:

Erythromycin (UNII: 63937KV33D) (Erythromycin - UNII:63937KV33D)

から入手可能:

Avera McKennan Hospital

INN（国際名）:

Erythromycin

構図:

Erythromycin 250 mg

処方タイプ:

PRESCRIPTION DRUG

認証ステータス:

Abbreviated New Drug Application

製品の特徴

ERYTHROMYCIN- ERYTHROMYCIN TABLET, FILM COATED
AVERA MCKENNAN HOSPITAL
----------
ERYTHROMYCIN
TABLETS, USP
Film-coated Tablets
RX ONLY
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of Erythromycin
Tablets and other antibacterial drugs, Erythromycin Tablets should be
used only to treat or prevent
infections that are proven or strongly suspected to be caused by
bacteria.
DESCRIPTION
Erythromycin Tablets, USP are an antibacterial product containing
erythromycin, USP, in a unique,
nonenteric film coating for oral administration. Erythromycin Tablets
are available in two strengths
containing either 250 mg or 500 mg of erythromycin base.
Erythromycin is produced by a strain of _Saccharopolyspora erythraea_
(formerly _Streptomyces erythraeus_)
and belongs to the macrolide group of antibiotics. It is basic and
readily forms salts with acids.
Erythromycin is a white to off-white powder, slightly soluble in
water, and soluble in alcohol,
chloroform, and ether. Erythromycin is known chemically as (3R*, 4S*,
5S*, 6R*, 7R*, 9R*, 11R*,
12R*, 13S*,
14R*)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-??-L-_ribo_-hexopyranosyl)oxy]-14-ethyl-
7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-??-D-_xylo_
-
hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione. The molecular
formula is C
H NO , and the
molecular weight is 733.94. The structural formula is:
INACTIVE INGREDIENTS
Colloidal silicon dioxide, croscarmellose sodium, crospovidone, D&C
Red No. 30 Aluminum Lake,
hydroxypropyl cellulose, hypromellose, hydroxypropyl methylcellulose
phthalate, magnesium stearate,
microcrystalline cellulose, povidone, polyethylene glycol, propylene
glycol, sodium citrate, sodium
hydroxide, sorbic acid, sorbitan monooleate, talc, and titanium
dioxide.
CLINICAL PHARMACOLOGY
37
67
13
Orally administered erythromycin base and its salts are readily
absorbed in the microbiologically active
form. Interindividual variations in the absorption of erythromycin
are, however, observed, and some
patients